Subscribe To
Cematrix to report third quarter results on november 8, 2023 earnings webinar scheduled for 1:00 p.m. et, november 9, 2023
CALGARY, Alberta, Nov. 02, 2023 (GLOBE NEWSWIRE) -- CEMATRIX Corporation (TSXV: CVX) (OTCQB: ctxXF) ("C...
November 2, 2023, 8:30 am
Mirum pharmaceuticals: an attractive stock to watch for its liver disease franchise
Mirum Pharmaceuticals has two drugs, maralixibat and volixibat, targeting rare liver diseases involving cholestasis. The company's lead program, maral...
September 24, 2023, 3:51 am
Cingulate announces detailed trial results from phase 3 adult efficacy and safety trial of ctx-1301 (dexmethylphenidate) for adhd
ctx-1301 Demonstrated Clinically Meaningful Improvements in Permanent Product Measure of Performance (P...
September 11, 2023, 10:00 am
Cematrix corporation (ctxxf) q2 2023 earnings call transcript
CEMATRIX Corporation (OTCQB:ctxXF) Q2 2023 Earnings Conference Call August 10, 2023 1:00 PM ET Company ...
August 13, 2023, 4:57 am
Lineage cell (lctx) reports q2 loss, tops revenue estimates
Lineage Cell (Lctx) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estima...
August 10, 2023, 6:16 pm
Cematrix to report second quarter results on august 9, 2023 – earnings webinar scheduled for 1:00 p.m. est, august 10, 2023
CALGARY, Alberta, Aug. 04, 2023 (GLOBE NEWSWIRE) -- CEMATRIX Corporation (TSXV: CVX) (OTCQB: ctxXF) ("C...
August 4, 2023, 3:18 pm
Crispr therapeutics: potential beyond current bla filing of exa-cel
Patients are currently being enrolled by CRISPR Therapeutics AG in a potentially pivotal single-arm phase 2 study using ...
May 18, 2023, 3:45 pm
Lineage cell therapeutics, inc. (lctx) q1 2023 earnings call transcript
Lineage Cell Therapeutics, Inc. (NYSE:Lctx ) Q1 2023 Results Conference Call May 11, 2023 4:30 PM ET Co...
May 11, 2023, 10:29 pm
Cingulate announces successful transfer of ctx-1301 (dexmethylphenidate) proprietary ptr™ manufacturing processes to societal cdmo
Scalable Supply of ctx-1301 Ready to be Produced with Cingulate on Track to Meet Previously Announced C...
May 3, 2023, 10:45 am
Buy crispr therapeutics on approval odds
ctx001 has progressed enough to start discussing details regarding the launch of the program. Regulator...
March 31, 2023, 4:07 am
Lineage cell therapeutics, inc. (lctx) q4 2022 earnings call transcript
Lineage Cell Therapeutics, Inc. (NYSE:Lctx ) Q4 2022 Earnings Conference Call March 9, 2023 4:30 PM ET ...
March 9, 2023, 11:19 pm
Lineage cell (lctx) reports q4 loss, misses revenue estimates
Lineage Cell (Lctx) delivered earnings and revenue surprises of 0% and 35.46%, respectively, for the qu...
March 9, 2023, 7:02 pm
Why is cingulate (cing) stock up 72% today?
Cingulate (NASDAQ: CING ) stock is on the rise Friday after releasing positive data concerning its ADHD treatment. The big news today is Cingulate's <...
February 24, 2023, 7:47 am
Citrix systems, inc.: please contact the portnoy law firm to recover your losses; february 13, 2023 deadline
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 09, 2023 (GLOBE NEWSWIRE) — The Portnoy ...
February 9, 2023, 5:27 am
Citius pharmaceuticals to present at the sidoti micro-cap virtual conference on january 18, 2023
CRANFORD, N.J. , Jan. 11, 2023 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: ...
January 11, 2023, 8:30 am
ctxs, gaia & dakt class action reminders: bronstein, gewirtz & grossman, llc, a successful firm, reminds investors of deadlines and to actively participate
NEW YORK, Jan. 06, 2023 (GLOBE NEWSWIRE) — Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit h...
January 6, 2023, 3:02 pm
Cingulate initiates phase 3 study of lead asset ctx-1301, designed as a true entire active-day treatment for adhd
Trial Results Expected 1H 2023 Company to Host Investor and Business Development Meetings Adjacent to Upcoming J.P. Morgan Healthcare Conference in Sa...
January 4, 2023, 11:45 am
Cematrix to host investor webcast on december 13, 2022
CALGARY, Alberta, Dec. 06, 2022 (GLOBE NEWSWIRE) -- CEMATRIX Corporation (TSXV: CVX) (OTCQB: ctxXF) ("C...
December 6, 2022, 8:30 am
Lineage to present at btig ophthalmology day and the cantor fitzgerald medical & aesthetic dermatology, ophthalmology & medtech conference
CARLSBAD, Calif.--( BUSINESS WIRE )--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: Lctx), a ...
November 29, 2022, 8:00 am
Lineage cell therapeutics, inc. (lctx) q3 2022 earnings call transcript
Lineage Cell Therapeutics, Inc. (NYSE:Lctx ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM...
November 10, 2022, 8:35 pm